Because of the effort of the
investigations about idiopathic pulmonary fibrosis treatment, known as the most
aggressive and lethal lung disease, mexican scientists from the Respiratory
Diseases National Institute “Ismael Cosio Villegas”, received a recognition by
the American Thoracic Society.
The experts, leaded by doctor Moises
Selman Lama, became the very first non american scientists who received the
recognition, by ranking between the world’s most important group of specialists
dedicated to the study of this medical condition.
Among its most significant contributions,
highlights a medical study, presented together with National Autonomous
University of Mexico, about the idiopathic cystic fibrosis, which demonstrates
that it’s not about an inflammatory chronic condition, as they knew half
The article published with the
title: “Idiopathic pulmonary fibrosis: prevailing and in evolution. Hypothesis
about pathogenesis and implications for the therapy”, allowed knowing some
mechanisms that made this disease more understandable.
As a result of that, the treatment
was modified; it was based on powerful anti-inflammatory and immunosuppressant
medication, that wasn’t effectively to stop the disease, and created severs
secondary effects to the patients.
Doctor Selman Lama pointed that the
studies provide modifications in the treatment, as well as in the assignations
of resources by the Health Institutes of the United States, who didn’t finance
investigations that consider the disease as an inflammatory process.
From that work, they started to make
clinical rehearses with another kind of substances for this disease treatment,
which allowed the authorization of new medications by the Food and Drug
In 1936, during the presidency of
the General Lázaro Cardenas, was founded with the name of Sanatorium for
Tuberculosis Patients of Huipulco, and in 1982, became the Respiratory Diseases
National Institute, with the assignments of medical and educational assistance,
as well as scientific and technical researching with specialty on neumology.
Follow us on Twitter: @SSalud_mx y @_MJuan_